Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Comparison of Clinical Characteristics and Prognosis of a Series of Patients from the Spanish Registry of MDS Diagnosed with Myelodysplastic/Myeloproliferative Neoplasms According to the 2016 Reviewed Classification of the World Health Organization

Blood (2018) 132 (Supplement 1): 3048.

https://doi.org/10.1182/blood-2018-99-111883

Published: 2018

Journal Articles

Germline and Acquired Genetic Variants in Myelodysplastic Syndromes in Young Adults without a Preexisting Disorder or Organ Dysfunction

Blood (2018) 132 (Supplement 1): 4339.

https://doi.org/10.1182/blood-2018-99-116045

Published: 2018

Journal Articles

Usefulness of a Sequencing Panel in Myeloproliferative Neoplasms Lacking Mutations in Driver Genes

Pamela Acha, Marisol Xandri, Francisco Fuster-Tormo, MSc, Laura Palomo, MSc, Blanca Xicoy, PhD, Marta Cabezón, Silvia Marcé, PhD, Francesc Sole, PhD, Lurdes Zamora, PhD

Blood (2017) 130 (Supplement 1): 1651.

https://doi.org/10.1182/blood.V130.Suppl_1.1651.1651

Published: 2017

Journal Articles

A Novel Single Next-Generation Sequencing (NGS) Approach for the Molecular Karyotyping and Genotyping of Patients with Myelodysplastic Syndromes

Blood (2017) 130 (Supplement 1): 1700.

https://doi.org/10.1182/blood.V130.Suppl_1.1700.1700

Published: 2017

Journal Articles

Transcriptome of DNA Repair Genes in CMML: Rationale for Targeting ERCC1 and CDKN1A As a Synthetic Lethality Approach

Blood (2017) 130 (Supplement 1): 1679.

https://doi.org/10.1182/blood.V130.Suppl_1.1679.1679

Published: 2017

Journal Articles

Application of Trusight Myeloid Panel on Whole Genome Amplified DNA in Myelodysplastic Syndrome Patients

Laura Palomo, MSc, Daniel Alvira, MSc, Francisco Fuster-Tormo, MSc, Vera Ademà, PhD, Maria Pilar Armengol, PhD, Paula Gomez-Marzo, MSc, Nuri de Haro, Mar Mallo, PhD, Blanca Xicoy, MD, Lurdes Zamora, PhD, Francesc Sole, PhD

Blood (2016) 128 (22): 5519.

https://doi.org/10.1182/blood.V128.22.5519.5519

Published: 2016

Journal Articles

Comparison of the Molecular Spectrum of Lenalidomide-Treated Myelodysplastic Syndrome with and without Del(5q)

Blood (2016) 128 (22): 3172.

https://doi.org/10.1182/blood.V128.22.3172.3172

Published: 2016

Journal Articles

In MDS Targeted Deep Sequencing of CD34 + Blood Cells but Not Peripheral Blood Mononuclear Cells Give Results Which Are Representative for Bone Marrow

Roman Martin, PhD, Laura Palomo, MSc, Christina Ganster, PhD, Pamela Acha, Sascha Dierks, PhD, Mar Mallo, PhD, Vera Adema, Francisco Fuster-Tormo, MSc, Paula Gomez-Marzo, MSc, Nuria De Haro, Neus Solanes, Lurdes Zamora, PhD, Blanca Xicoy, MD, Arkadiusz Kominowski, Martin Stromburg, Alina Brockmann, Lorenz H. Truemper, MD PhD, Francesc Sole, PhD, Detlef Haase, MD

Blood (2016) 128 (22): 2383.

https://doi.org/10.1182/blood.V128.22.2383.2383

Published: 2016

Journal Articles

The Complete Mutatome and Clonal Architecture of Del(5q)

Vera Ademà, MSc, Laura Palomo, MSc, Przychodzen P Bartlomiej, Diez-campelo Maria, MD, Naoko Hosono, MD PhD, Mar Mallo, PhD, Blanca Xicoy, MD PhD, Elisa Luño, Bhumika J. Patel, Cassandra M Hirsch, Lurdes Zamora, PhD, Thomas LaFramboise, PhD, Leonor Arenillas, MD, Albert Perez-Ladaga, PhD, Carme Pedro, Michael J. Clemente, Joan Bargay, MD, Julia Montoro, MD, Juan Carlos Caballero, MD, Brayan Merchan, MD, Victor Noriega, MD, Victor Marcos-Betes, MD, Consuelo Del Cañizo, MD PhD, Rosario Lopez, PhD, José María Raya, MD, Joaquin Sanchez-Garcia, MD, Eduardo Rios, Montserrat Arnan, MD PhD, Lourdes Florensa, MD PhD, Raquel de Paz, Angelina Lemes, MD, Paula Gomez-Marzo, MSc, Nuri Haro, Francisco Fuster-Tormo, MSc, Monica Bayes, PhD, Ivo Gut, Rafael Bejar, MDPhD, Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski, MD PhD, Francesc Sole, PhD

Blood (2015) 126 (23): 608.

https://doi.org/10.1182/blood.V126.23.608.608

Published: 2015

Journal Articles

Downregulation of BAP1 in Chronic Myelomonocytic Leukemia: Correlated with a Post-Translational Reduction of BRCA1 Levels and Independent of Promoter Methylation

Ana María Hurtado, Gines Luengo-Gil, Laura Palomo, MSc, Eva Lumbreras, Eva Caparrós, Tzu Hua Chen-Liang, Bartlomiej Przychodzen, MSc, Maria Luz Amigo, María Díez-Campelo, MD PhD, Lurdes Zamora, PhD, Francisco José Ortuño, Raul Teruel Montoya, PhD, Jaroslaw P. Maciejewski, MD PhD, Consuelo Del Cañizo, MD PhD, Francesc Sole, PhD, Francisca Ferrer-Marin, Andres Jerez

Blood (2015) 126 (23): 1648.

https://doi.org/10.1182/blood.V126.23.1648.1648

Published: 2015

Journal Articles

Mutational Studies Using Next Generation Sequencing in High Risk Myelodysplastic Syndromes and Secondary Acute Myeloid Leukemia Patients Treated with Azacitidine (High risk MDS 2009 protocol from CETLAM Group)

Blood (2015) 126 (23): 2905.

https://doi.org/10.1182/blood.V126.23.2905.2905

Published: 2015

Journal Articles

Molecular Genetic Profiling in Chronic Myelomonocytic Leukemia with Low Risk Cytogenetic Features

Laura Palomo, MSc, Blanca Xicoy, MD PhD, Montse Arnan, MD, Marta Cabezon, Rosa Coll, MD, Vera Ademà, MSc, Francisco Fuster, MSc, Javier Grau, MD, María José Jiménez, Helena Pomares, MD, Sílvia Marcé, PhD, Maria Pilar Armengol, PhD, Mar Mallo, PhD, Fuensanta Millá, MD PhD, Evarist Feliu, MD PhD, Francesc Sole, PhD, Lurdes Zamora, PhD

Blood (2015) 126 (23): 2883.

https://doi.org/10.1182/blood.V126.23.2883.2883

Published: 2015

NARROW

Comparison of Clinical Characteristics and Prognosis of a Series of Patients from the Spanish Registry of MDS Diagnosed with Myelodysplastic/Myeloproliferative Neoplasms According to the 2016 Reviewed Classification of the World Health Organization

Germline and Acquired Genetic Variants in Myelodysplastic Syndromes in Young Adults without a Preexisting Disorder or Organ Dysfunction

Usefulness of a Sequencing Panel in Myeloproliferative Neoplasms Lacking Mutations in Driver Genes

A Novel Single Next-Generation Sequencing (NGS) Approach for the Molecular Karyotyping and Genotyping of Patients with Myelodysplastic Syndromes

Transcriptome of DNA Repair Genes in CMML: Rationale for Targeting ERCC1 and CDKN1A As a Synthetic Lethality Approach

Application of Trusight Myeloid Panel on Whole Genome Amplified DNA in Myelodysplastic Syndrome Patients

Comparison of the Molecular Spectrum of Lenalidomide-Treated Myelodysplastic Syndrome with and without Del(5q)

In MDS Targeted Deep Sequencing of CD34 + Blood Cells but Not Peripheral Blood Mononuclear Cells Give Results Which Are Representative for Bone Marrow

The Complete Mutatome and Clonal Architecture of Del(5q)

Downregulation of BAP1 in Chronic Myelomonocytic Leukemia: Correlated with a Post-Translational Reduction of BRCA1 Levels and Independent of Promoter Methylation

Mutational Studies Using Next Generation Sequencing in High Risk Myelodysplastic Syndromes and Secondary Acute Myeloid Leukemia Patients Treated with Azacitidine (High risk MDS 2009 protocol from CETLAM Group)

Molecular Genetic Profiling in Chronic Myelomonocytic Leukemia with Low Risk Cytogenetic Features

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only